Head & Neck + Colorectal Cancer Treatment

Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)? 74

Of these how many are treated with the following therapies;

• Carboplatin – 4
• Cetuximab – 12
• Cisplatin – 14
• Docetaxel – 0
• 5-Fluorouracil (5FU) – 8
• Radiotherapy Only – 21

Please note, if a patient has received a combination of chemotherapy treatment (ie. Carboplatin and 5FU) these has been included in both therapy counts.

If your health trust has a protocol or pathway for the treatment of head and neck cancer patients [including referral pathway to other trusts], please could you provide details?

Patient pathway

Within your health trust how many patients are currently [within the past 6 months] being treated for Colorectal Cancer? 325
Of these how many are treated with the following therapies;

• Bevacizumab – 3
• Cetuximab – 46
• Panitumumab – 4
• Aflibercept – 5
• Oxaliplatin – 241
• Irinotecan – 99
• 5-Fluorouracil – 3
• Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI] – 0
• Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX] – 0
• Capecitabine and oxalipatin (CAPOX / XELOX) – 25
• Capecitabine and irinitecan (CAPIRI) – 0

©2017 Royal Surrey County Hospital

Log in with your credentials

Forgot your details?